stockportfolio.pro
Stocks / BMEZ vs NXP
BMEZ vs NXP
BlackRock Health Sciences Term Trust and Nuveen Select Tax-Free Income Portfolio side by side — fundamentals from SEC filings, refreshed nightly. Sector: Financial Services.
| BlackRock Health Sciences Term Trust (BMEZ) | Nuveen Select Tax-Free Income Portfolio (NXP) | |
|---|---|---|
| Market cap | $0.9B | $0.9B |
| Revenue (latest FY) | $0 | $29.54M |
| Net income (latest FY) | $0 | $29.17M |
| Revenue growth (5y CAGR) | — | 626.0% |
| Net margin | — | 98.7% |
| Return on equity | — | 3.3% |
| P/E ratio | 5.6 | 25.2 |
| Dividend yield | 9.3% | 4.5% |
| Profitable years (of last 10) | 0 | 3 |
| Positive free cash flow | — | — |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open BMEZ — free Open NXP — freeFrequently asked questions
Which is bigger, BMEZ or NXP?
Nuveen Select Tax-Free Income Portfolio is larger by market capitalization — $0.9B versus $0.9B.
Which grows faster, BMEZ or NXP?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.